These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 22103901

  • 1. Breast cancer patients with hypermethylation in the promoter of BRCA1 gene exhibit favorable clinical status.
    Krasteva ME, Bozhanov SS, Antov GG, Gospodinova ZI, Angelov SG.
    Neoplasma; 2012; 59(1):85-91. PubMed ID: 22103901
    [Abstract] [Full Text] [Related]

  • 2. Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer.
    Bozhanov SS, Angelova SG, Krasteva ME, Markov TL, Christova SL, Gavrilov IG, Georgieva EI.
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1657-69. PubMed ID: 20177704
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.
    Life Sci; 2010 Jul 17; 87(3-4):83-91. PubMed ID: 20470789
    [Abstract] [Full Text] [Related]

  • 4. Negative/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma.
    Karray-Chouayekh S, Trifa F, Khabir A, Sellami-Boudawara T, Frikha M, Gargouri A, Mokdad-Gargouri R.
    Histol Histopathol; 2012 Mar 17; 27(3):377-85. PubMed ID: 22237715
    [Abstract] [Full Text] [Related]

  • 5. ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma.
    Seniski GG, Camargo AA, Ierardi DF, Ramos EA, Grochoski M, Ribeiro ES, Cavalli IJ, Pedrosa FO, de Souza EM, Zanata SM, Costa FF, Klassen G.
    BMC Cancer; 2009 Mar 06; 9():80. PubMed ID: 19267929
    [Abstract] [Full Text] [Related]

  • 6. Promoter methylation patterns of ATM, ATR, BRCA1, BRCA2 and p53 as putative cancer risk modifiers in Jewish BRCA1/BRCA2 mutation carriers.
    Kontorovich T, Cohen Y, Nir U, Friedman E.
    Breast Cancer Res Treat; 2009 Jul 06; 116(1):195-200. PubMed ID: 18642075
    [Abstract] [Full Text] [Related]

  • 7. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
    Yadav P, Masroor M, Nandi K, Kaza RCM, Jain SK, Khurana N, Saxena A.
    Asian Pac J Cancer Prev; 2018 Feb 26; 19(2):443-448. PubMed ID: 29480000
    [Abstract] [Full Text] [Related]

  • 8. Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.
    Aloraifi F, Alshehhi M, McDevitt T, Cody N, Meany M, O'Doherty A, Quinn CM, Green AJ, Bracken A, Geraghty JG.
    Eur J Surg Oncol; 2015 May 26; 41(5):641-6. PubMed ID: 25736863
    [Abstract] [Full Text] [Related]

  • 9. Regulation of DNA methyltransferase 1 transcription in BRCA1-mutated breast cancer: a novel crosstalk between E2F1 motif hypermethylation and loss of histone H3 lysine 9 acetylation.
    Li D, Bi FF, Cao JM, Cao C, Liu B, Yang Q.
    Mol Cancer; 2014 Feb 06; 13():26. PubMed ID: 24502362
    [Abstract] [Full Text] [Related]

  • 10. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
    Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG.
    J Natl Cancer Inst; 2000 Apr 05; 92(7):564-9. PubMed ID: 10749912
    [Abstract] [Full Text] [Related]

  • 11. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD, Ralhan R.
    Life Sci; 2007 Jul 04; 81(4):280-7. PubMed ID: 17599361
    [Abstract] [Full Text] [Related]

  • 12. Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.
    Hsu NC, Huang YF, Yokoyama KK, Chu PY, Chen FM, Hou MF.
    PLoS One; 2013 Jul 04; 8(2):e56256. PubMed ID: 23405268
    [Abstract] [Full Text] [Related]

  • 13. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.
    Sharma G, Mirza S, Yang YH, Parshad R, Hazrah P, Datta Gupta S, Ralhan R.
    Cell Oncol; 2009 Jul 04; 31(6):487-500. PubMed ID: 19940364
    [Abstract] [Full Text] [Related]

  • 14. Analysis of FHIT gene methylation in egyptian breast cancer women: association with clinicopathological features.
    Zaki SM, Abdel-Azeez HA, El Nagar MR, Metwally KA, S Ahmed MM.
    Asian Pac J Cancer Prev; 2015 Jul 04; 16(3):1235-9. PubMed ID: 25735361
    [Abstract] [Full Text] [Related]

  • 15. Methylation biomarkers for pleomorphic lobular breast cancer - a short report.
    Moelans CB, Vlug EJ, Ercan C, Bult P, Buerger H, Cserni G, van Diest PJ, Derksen PW.
    Cell Oncol (Dordr); 2015 Oct 04; 38(5):397-405. PubMed ID: 26392358
    [Abstract] [Full Text] [Related]

  • 16. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.
    Miyamoto K, Fukutomi T, Asada K, Wakazono K, Tsuda H, Asahara T, Sugimura T, Ushijima T.
    Jpn J Clin Oncol; 2002 Mar 04; 32(3):79-84. PubMed ID: 11956301
    [Abstract] [Full Text] [Related]

  • 17. Histopathological features of breast cancer in carriers of ATM gene variants.
    Balleine RL, Murali R, Bilous AM, Farshid G, Waring P, Provan P, Byth K, Thorne H, kConFab Investigators, Kirk JA.
    Histopathology; 2006 Nov 04; 49(5):523-32. PubMed ID: 17064299
    [Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.
    Rio PG, Pernin D, Bay JO, Albuisson E, Kwiatkowski F, De Latour M, Bernard-Gallon DJ, Bignon YJ.
    Int J Oncol; 1998 Oct 04; 13(4):849-53. PubMed ID: 9735416
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Methylation of the BRCA1 gene in sporadic breast cancer.
    Dobrovic A, Simpfendorfer D.
    Cancer Res; 1997 Aug 15; 57(16):3347-50. PubMed ID: 9269993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.